HopeStage
Back to overview

Depression studies

Topics
More filters

Depression

Depression involves persistent low mood or loss of interest, often with tiredness and changes in sleep or appetite.

7264studies shown
Showing 1,669-1,680 of 7,264
Drug study icon
CompletedACTRN12613001299796

Nutraceuticals as Monotherapy Treatments in Major Depressive Disorder: A study

Official study title

The Efficacy of S-Adenosyl Methionine (SAMe) and a Combination Nutraceutical as Monotherapy Treatments in Major Depressive Disorder: A Double-Blind, Randomised, Placebo-Controlled Trial

This study has finished and is no longer accepting participants.

Multiple locations, including Richmond
DepressionInterventional studyAges 18–70
Countries
Australia
Sponsor
University of Melbourne
Other study type icon
CompletedACTRN12609000925246

Promotion of self-help strategies for sub-threshold depression: An e-mental health controlled study

Official study title

For adult internet users with sub-threshold depression, is receiving email messages promoting self-help strategies more effective than receiving email messages with general information about depression, for reducing depressive symptoms and preventing major depression?

This study has finished and is no longer accepting participants.

In Canada
DepressionInterventional studyAges 18+
Countries
United States, Canada, United Kingdom, + 2 others
Sponsor
University of Melbourne
Other study type icon
CompletedACTRN12621000181808

The PRESIDE study

Official study title

The PRESIDE (PhaRmacogEnomicS In Depression) Trial: a double-blind RCT of pharmacogenomically-informed prescribing of antidepressants on depression outcomes in patients with major depressive disorder in primary care.

This study has finished and is no longer accepting participants.

In Australia
DepressionInterventional studyAges 18–65
Countries
Australia
Sponsor
The University of Melbourne
Drug study icon
Not Yet RecruitingEUCTR 2021-002604-12

Unraveling the aesthetic mind in anhedonia, insights from pharmacological imaging of the human brain: A single-blind, randomized, placebo-controlled cross-over study

This study isn't recruiting yet.

This study transferred to CTIS. HopeStage uses that newer record for the displayed status. A country's status does not guarantee that an individual site accepts participants.

In Vienna
DepressionHistorical research record
Countries
Austria
Sponsor
Medical University of Vienna
Drug study icon
CompletedEUCTR 2015-002658-11

Long-term, open-label, flexible-dose, continuation extension study with vortioxetine in child and adolescent patients with Major Depressive Disorder (MDD) from 7 to 17 years of age

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Belgium
DepressionHistorical research record
Countries
France, United Kingdom, Belgium, + 8 others
Sponsor
H. Lundbeck A/S

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.